PacBio Sales Start to Pick Up as Company Delivers on Product Enhancements | GenomeWeb

This article was originally published February 6.

Following a slow start to 2012, sales of the Pacific Biosciences RS system began to pick up in the second half of the year, with five systems booked in the fourth quarter and four in the previous quarter — a marked improvement over three booked in the first half of the year.

The company also installed five systems in the fourth quarter of 2012, bringing its total installed base to 71. It ended the year with a backlog of five instruments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.